Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Potential of Daridorexant in Healthy Recreational Drug Users
NCT03657355Phase 1Completed
- Sponsor
- Idorsia
- Start
- Sep 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of daridorexant in Insomnia (6 arms), sponsored by Idorsia. Primary endpoint: Maximum effect (Emax) of the Drug Liking Visual Analog Scale at 24 hours. Started Sep 2018; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT03657355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03657355.